Marshall Financial Group (Maryland)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-427
Closed -$223K – 174
2023
Q2
$223K Sell
427
-47
-10% -$25.4K 0.08% 163
2023
Q1
$273K Sell
474
-1,462
-76% -$824K 0.1% 154
2022
Q4
$1.07M Buy
1,936
+163
+9% +$86.4K 0.41% 78
2022
Q3
$899K Sell
1,773
-40
-2% -$22.4K 0.38% 75
2022
Q2
$985K Buy
1,813
+1,397
+336% +$769K 0.39% 70
2022
Q1
$246K Sell
416
-50
-11% -$28.7K 0.1% 187
2021
Q4
$311K Buy
+466
New +$291K 0.11% 176

Other funds holding TMO

Marshall Financial Group (Maryland)'s TMO Position: Q3 2023 in Review

Marshall Financial Group (Maryland) sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 427 shares — an estimated $223K sold.

Marshall Financial Group (Maryland) first reported a position in TMO in Q4 2021 and held it in 7 quarters. The position peaked at $1.07M in Q4 2022. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Marshall Financial Group (Maryland) reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Marshall Financial Group (Maryland) sold 427 Thermo Fisher Scientific shares in Q3 2023, an estimated $223K.
  • Marshall Financial Group (Maryland) first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 7 quarters.
  • Marshall Financial Group (Maryland)'s Thermo Fisher Scientific position peaked at $1.07M in Q4 2022.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q3 2023, filed 19 Oct 2023.